← All organizations

iTeos Therapeutics

For profitWebsite ↗

Also known as: iTeos Belgium SA | iTeos Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 7, 2025

Acquired by Concentra on Oct 1, 2025

Timeline

2010s

Jan 1, 2011
iTeos Therapeutics— Founded

2020s

Oct 1, 2025
Concentra— Acquired By

Drugs by trial phase (15 distinct, 12 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (9 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Neoplasms

Recent trials (16)

NCT06877533OfficialPhase 1Apr 7, 2025
NCT06877533Lead sponsorPhase 1Apr 7, 2025
NCT06472076CollaboratorPhase 3Jun 10, 2024
NCT06062420CollaboratorPhase 2Oct 4, 2023
NCT06547957Lead sponsorPhase 1Jul 7, 2023
NCT05565378CollaboratorPhase 2Oct 14, 2022
NCT05403385Lead sponsorPhase 2Aug 26, 2022
NCT05289492CollaboratorPhase 1/Phase 2May 1, 2022
NCT05289492OfficialPhase 1/Phase 2May 1, 2022
NCT05289492Study directorPhase 1/Phase 2May 1, 2022
NCT05289492Lead sponsorPhase 1/Phase 2May 1, 2022
NCT05060432Lead sponsorPhase 1/Phase 2Sep 6, 2021
NCT05117177Lead sponsorPhase 1Jul 14, 2021
NCT04335253Lead sponsorPhase 1Feb 18, 2020
NCT03873883Lead sponsorPhase 1Jan 28, 2019

Details

Founded: Gosselies, BE Jan 1, 2011
Last known activity: Apr 7, 2025